Unlocking Efficiency in Formulation Development and Approvals with MIFD & Simcyp Biopharmaceutics [APAC Webinar] On-Demand Webinar 利用 MIFD 和 Simcyp Biopharmaceutics 轻松提升制剂开发效率并加速审批效率【亚太地区网络讲座】 Biopharmaceutical professionals can gain a significant edge in formulation development by attending this free webinar…Certara2024 年 5 月 16 日
Reflections on the New FDA Clinical Pharmacology Guidance for Antibody-Drug Conjugates Blog 对 FDA 新抗体-药物偶联物临床药理指南的思考 In recent years, oncology drug developers have invested in antibody-drug conjugates (ADCs). These targeted therapies…Certara2024 年 5 月 10 日
CERTARA & CLOUDSCIENTIFIC ACCELERATE AI FOR DRUG DEVELOPMENT IN CHINA Announcement Certara 与康昱盛携手加速中国药物研发的人工智能进程 Partnership will provide biopharmaceutical companies with advanced tools and solutions needed to expedite research …Certara2024 年 5 月 10 日
Accelerate your drug discovery research with D360 and Design Hub Fact Sheet Accelerate your drug discovery research with D360 and Design Hub Certara2024 年 5 月 10 日
CERTAINTY – Japan Live Events CERTAINTY – 日本 GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical…Certara2024 年 5 月 7 日
CERTAINTY – China Live Events CERTAINTY – 中国 GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical researchers…Certara2024 年 5 月 7 日
CERTAINTY – South Korea Live Events CERTAINTY – 韩国 GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical…Certara2024 年 5 月 7 日
Certara Reports First Quarter 2024 Financial Result Press Release Certara 公布 2024 年第一季度财报 Reiterates Full Year 2024 Financial Guidance PRINCETON, N.J.— May 7, 2024-- Certara, Inc. (纳斯达克股票代码:CERT), a…Certara2024 年 5 月 7 日
Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future Publication 通过 PBPK 建模优化剂量:最新技术与未来 The article "Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future" by Karen Rowland…Certara2024 年 5 月 6 日